{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-021019","form_type":"8-K","ticker":"IMNN","cik":"0000749647","company_name":"Imunon, Inc.","filed_at":"2026-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.700534+00:00","generated_at":"2026-05-15T00:09:24.167816+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Imunon enters change of control severance agreements with CEO, CMO, and GC","bullets":["CEO Lindborg gets 2.5x base salary plus target bonus severance; others get 1.5x.","COBRA coverage: 24 months for CEO, 18 months for CMO and GC.","All unvested equity awards fully accelerate upon qualifying termination in change-of-control window.","Effective May 1, 2026; trigger period is 4 months before to 1 year after a change of control.","Benefits require a release of claims; 1-year non-compete covenant applies."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021019","json":"https://secwatch.observer/filing/0001493152-26-021019.json","markdown":"https://secwatch.observer/filing/0001493152-26-021019.md","text":"https://secwatch.observer/filing/0001493152-26-021019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/749647/000149315226021019/0001493152-26-021019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/749647/000149315226021019/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T00:09:24.167816+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}